nodes	percent_of_prediction	percent_of_DWPC	metapath
Terconazole—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.0309	0.0309	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.0224	0.0224	CcSEcCtD
Terconazole—Chills—Dactinomycin—muscle cancer	0.0213	0.0213	CcSEcCtD
Terconazole—Bronchospasm—Etoposide—muscle cancer	0.0211	0.0211	CcSEcCtD
Terconazole—Ill-defined disorder—Dactinomycin—muscle cancer	0.0192	0.0192	CcSEcCtD
Terconazole—Malaise—Dactinomycin—muscle cancer	0.0187	0.0187	CcSEcCtD
Terconazole—Myalgia—Dactinomycin—muscle cancer	0.0176	0.0176	CcSEcCtD
Terconazole—Discomfort—Dactinomycin—muscle cancer	0.0174	0.0174	CcSEcCtD
Terconazole—Influenza like illness—Doxorubicin—muscle cancer	0.0172	0.0172	CcSEcCtD
Terconazole—Myalgia—Vincristine—muscle cancer	0.0157	0.0157	CcSEcCtD
Terconazole—Chills—Etoposide—muscle cancer	0.0154	0.0154	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.0154	0.0154	CcSEcCtD
Terconazole—Anaphylactic shock—Vincristine—muscle cancer	0.0151	0.0151	CcSEcCtD
Terconazole—Pain—Dactinomycin—muscle cancer	0.0144	0.0144	CcSEcCtD
Terconazole—Feeling abnormal—Dactinomycin—muscle cancer	0.0139	0.0139	CcSEcCtD
Terconazole—Ill-defined disorder—Etoposide—muscle cancer	0.0139	0.0139	CcSEcCtD
Terconazole—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0138	0.0138	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Vincristine—muscle cancer	0.0137	0.0137	CcSEcCtD
Terconazole—Malaise—Etoposide—muscle cancer	0.0135	0.0135	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.0134	0.0134	CcSEcCtD
Terconazole—Abdominal pain—Dactinomycin—muscle cancer	0.0133	0.0133	CcSEcCtD
Terconazole—Body temperature increased—Dactinomycin—muscle cancer	0.0133	0.0133	CcSEcCtD
Terconazole—Pain—Vincristine—muscle cancer	0.0129	0.0129	CcSEcCtD
Terconazole—Discomfort—Etoposide—muscle cancer	0.0126	0.0126	CcSEcCtD
Terconazole—Face oedema—Doxorubicin—muscle cancer	0.0124	0.0124	CcSEcCtD
Terconazole—Hypersensitivity—Dactinomycin—muscle cancer	0.0124	0.0124	CcSEcCtD
Terconazole—Gastrointestinal pain—Vincristine—muscle cancer	0.0123	0.0123	CcSEcCtD
Terconazole—Anaphylactic shock—Etoposide—muscle cancer	0.0122	0.0122	CcSEcCtD
Terconazole—Asthenia—Dactinomycin—muscle cancer	0.0121	0.0121	CcSEcCtD
Terconazole—Abdominal pain—Vincristine—muscle cancer	0.0119	0.0119	CcSEcCtD
Terconazole—Body temperature increased—Vincristine—muscle cancer	0.0119	0.0119	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.0116	0.0116	CcSEcCtD
Terconazole—Hypersensitivity—Vincristine—muscle cancer	0.0111	0.0111	CcSEcCtD
Terconazole—Asthenia—Vincristine—muscle cancer	0.0108	0.0108	CcSEcCtD
Terconazole—Vomiting—Dactinomycin—muscle cancer	0.0107	0.0107	CcSEcCtD
Terconazole—Rash—Dactinomycin—muscle cancer	0.0106	0.0106	CcSEcCtD
Terconazole—Pain—Etoposide—muscle cancer	0.0104	0.0104	CcSEcCtD
Terconazole—Feeling abnormal—Etoposide—muscle cancer	0.0101	0.0101	CcSEcCtD
Terconazole—Nausea—Dactinomycin—muscle cancer	0.01	0.01	CcSEcCtD
Terconazole—Gastrointestinal pain—Etoposide—muscle cancer	0.00999	0.00999	CcSEcCtD
Terconazole—Dizziness—Vincristine—muscle cancer	0.00997	0.00997	CcSEcCtD
Terconazole—Urticaria—Etoposide—muscle cancer	0.00971	0.00971	CcSEcCtD
Terconazole—Abdominal pain—Etoposide—muscle cancer	0.00966	0.00966	CcSEcCtD
Terconazole—Body temperature increased—Etoposide—muscle cancer	0.00966	0.00966	CcSEcCtD
Terconazole—Vomiting—Vincristine—muscle cancer	0.00959	0.00959	CcSEcCtD
Terconazole—Rash—Vincristine—muscle cancer	0.00951	0.00951	CcSEcCtD
Terconazole—Dermatitis—Vincristine—muscle cancer	0.0095	0.0095	CcSEcCtD
Terconazole—Headache—Vincristine—muscle cancer	0.00945	0.00945	CcSEcCtD
Terconazole—Chills—Methotrexate—muscle cancer	0.00924	0.00924	CcSEcCtD
Terconazole—Hypersensitivity—Etoposide—muscle cancer	0.009	0.009	CcSEcCtD
Terconazole—Nausea—Vincristine—muscle cancer	0.00896	0.00896	CcSEcCtD
Terconazole—Asthenia—Etoposide—muscle cancer	0.00877	0.00877	CcSEcCtD
Terconazole—Pruritus—Etoposide—muscle cancer	0.00864	0.00864	CcSEcCtD
Terconazole—Ill-defined disorder—Methotrexate—muscle cancer	0.00832	0.00832	CcSEcCtD
Terconazole—Malaise—Methotrexate—muscle cancer	0.00809	0.00809	CcSEcCtD
Terconazole—Dizziness—Etoposide—muscle cancer	0.00808	0.00808	CcSEcCtD
Terconazole—Chills—Doxorubicin—muscle cancer	0.008	0.008	CcSEcCtD
Terconazole—Vomiting—Etoposide—muscle cancer	0.00777	0.00777	CcSEcCtD
Terconazole—Rash—Etoposide—muscle cancer	0.0077	0.0077	CcSEcCtD
Terconazole—Dermatitis—Etoposide—muscle cancer	0.0077	0.0077	CcSEcCtD
Terconazole—Headache—Etoposide—muscle cancer	0.00765	0.00765	CcSEcCtD
Terconazole—Arthralgia—Methotrexate—muscle cancer	0.00763	0.00763	CcSEcCtD
Terconazole—Myalgia—Methotrexate—muscle cancer	0.00763	0.00763	CcSEcCtD
Terconazole—Discomfort—Methotrexate—muscle cancer	0.00754	0.00754	CcSEcCtD
Terconazole—Anaphylactic shock—Methotrexate—muscle cancer	0.00732	0.00732	CcSEcCtD
Terconazole—Nausea—Etoposide—muscle cancer	0.00726	0.00726	CcSEcCtD
Terconazole—Ill-defined disorder—Doxorubicin—muscle cancer	0.0072	0.0072	CcSEcCtD
Terconazole—Malaise—Doxorubicin—muscle cancer	0.007	0.007	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00667	0.00667	CcSEcCtD
Terconazole—Arthralgia—Doxorubicin—muscle cancer	0.00661	0.00661	CcSEcCtD
Terconazole—Myalgia—Doxorubicin—muscle cancer	0.00661	0.00661	CcSEcCtD
Terconazole—Discomfort—Doxorubicin—muscle cancer	0.00653	0.00653	CcSEcCtD
Terconazole—Anaphylactic shock—Doxorubicin—muscle cancer	0.00634	0.00634	CcSEcCtD
Terconazole—Pain—Methotrexate—muscle cancer	0.00626	0.00626	CcSEcCtD
Terconazole—Feeling abnormal—Methotrexate—muscle cancer	0.00603	0.00603	CcSEcCtD
Terconazole—Gastrointestinal pain—Methotrexate—muscle cancer	0.00598	0.00598	CcSEcCtD
Terconazole—Urticaria—Methotrexate—muscle cancer	0.00581	0.00581	CcSEcCtD
Terconazole—Body temperature increased—Methotrexate—muscle cancer	0.00579	0.00579	CcSEcCtD
Terconazole—Abdominal pain—Methotrexate—muscle cancer	0.00579	0.00579	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00577	0.00577	CcSEcCtD
Terconazole—Pain—Doxorubicin—muscle cancer	0.00542	0.00542	CcSEcCtD
Terconazole—Hypersensitivity—Methotrexate—muscle cancer	0.00539	0.00539	CcSEcCtD
Terconazole—Asthenia—Methotrexate—muscle cancer	0.00525	0.00525	CcSEcCtD
Terconazole—Feeling abnormal—Doxorubicin—muscle cancer	0.00522	0.00522	CcSEcCtD
Terconazole—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00518	0.00518	CcSEcCtD
Terconazole—Pruritus—Methotrexate—muscle cancer	0.00518	0.00518	CcSEcCtD
Terconazole—Urticaria—Doxorubicin—muscle cancer	0.00503	0.00503	CcSEcCtD
Terconazole—Abdominal pain—Doxorubicin—muscle cancer	0.00501	0.00501	CcSEcCtD
Terconazole—Body temperature increased—Doxorubicin—muscle cancer	0.00501	0.00501	CcSEcCtD
Terconazole—Dizziness—Methotrexate—muscle cancer	0.00484	0.00484	CcSEcCtD
Terconazole—Hypersensitivity—Doxorubicin—muscle cancer	0.00467	0.00467	CcSEcCtD
Terconazole—Vomiting—Methotrexate—muscle cancer	0.00465	0.00465	CcSEcCtD
Terconazole—Rash—Methotrexate—muscle cancer	0.00461	0.00461	CcSEcCtD
Terconazole—Dermatitis—Methotrexate—muscle cancer	0.00461	0.00461	CcSEcCtD
Terconazole—Headache—Methotrexate—muscle cancer	0.00458	0.00458	CcSEcCtD
Terconazole—Asthenia—Doxorubicin—muscle cancer	0.00455	0.00455	CcSEcCtD
Terconazole—Pruritus—Doxorubicin—muscle cancer	0.00448	0.00448	CcSEcCtD
Terconazole—Nausea—Methotrexate—muscle cancer	0.00435	0.00435	CcSEcCtD
Terconazole—Dizziness—Doxorubicin—muscle cancer	0.00419	0.00419	CcSEcCtD
Terconazole—Vomiting—Doxorubicin—muscle cancer	0.00403	0.00403	CcSEcCtD
Terconazole—Rash—Doxorubicin—muscle cancer	0.004	0.004	CcSEcCtD
Terconazole—Dermatitis—Doxorubicin—muscle cancer	0.00399	0.00399	CcSEcCtD
Terconazole—Headache—Doxorubicin—muscle cancer	0.00397	0.00397	CcSEcCtD
Terconazole—Nausea—Doxorubicin—muscle cancer	0.00376	0.00376	CcSEcCtD
